Taz, right you are. The 14 mo OS data from the MD Anderson article also includes some patients whose disease was stable. It is really worth trying to parse out what the differences in patient population are between the "real world" Janssen study and and the other smaller studies referenced by Scarlett that showed "better" OS of 14 and 16 months. If the R/R patients are clearly closer to the real world patients in the course of their disease the results to date are even more spectacular. The acknowledgment of the other studies with better OS is a bid to be open and also say that even if the best case OS were 16 months, Imetelstat will still blow those results away regardless of what AF has to say. The data should be able to speak for itself. Who to believe...AF or Drs. Raza/Tefferi Hmmm... let me think. bp
